Qualigen Therapeutics to Rebrand as AIxCrypto After Shareholder Approval

The Nasdaq-listed firm plans to expand its C10 Treasury, grow BesTrade DeAI Agent globally, and launch a crypto ecosystem token by 2025.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.